Skip to the page

Data / Form D filings / Compass Therapeutics LLC

Compass Therapeutics LLC: Form D filings

Compass Therapeutics LLC, a biotechnology company in Cambridge, MA, filed 6 Form D notices with the SEC between 2014 and 2018. The latest, on July 16, 2018, reports $110.2 million sold of a $170.2 million offering to 20 investors.

Find out what Compass Therapeutics LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
245 FIRST STREET, Cambridge, MA, 02142
Phone
(617) 500-8099
Industry
Biotechnology
Entity type
Limited Liability Company
Incorporated in
Delaware
Year incorporated
2014
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1610824

The full lists. Form D filings in Massachusetts: 1,533 rows, $76.65, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Get the first 200 rows free

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jul 16, 2018Amendment$170,205,999$110,191,606$60,014,39320Jun 17, 2015sec.gov
Jan 8, 2018New notice$49,999,999$21,847,787$28,152,21214Dec 22, 2017sec.gov
Sep 21, 2016Amendment$170,205,999$45,977,738$124,228,26117Jun 17, 2015sec.gov
Jul 1, 2015New notice$120,977,535$15,977,535$105,000,00011Jun 17, 2015sec.gov
May 28, 2015Amendment$1,000,000$575,000$425,0004May 30, 2014sec.gov
Jun 13, 2014New notice$1,000,000$475,000$525,0003May 30, 2014sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
VERED J. BISKER-LEIBExecutive Officer
TIMOTHY J. ANDERSONDirector
PIOTR J. BOBROWICZExecutive Officer
PHILIP J. FERNEAUDirector
CARL J. GORDONDirector
DAMON J. BANKSExecutive Officer
THOMAS J. SCHUETZExecutive Officer, Director, Promoter
STEVEN J. SQUINTODirector
ERRIK J. ANDERSONDirector, Promoter
SARA J. MANNLEExecutive Officer
JEB J. LEDELLExecutive Officer
STEVE J. TREGAYDirector
BEN J. AUSPITZDirector

Other biotechnology companies in Massachusetts that filed recently

Every Form D from the week of Jul 16, 2018 · All recent filings in Massachusetts · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Compass Therapeutics LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.